These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35448525)

  • 21. Abdelazim and Sakiyeva endocrinopathy associated with polycystic ovary syndrome: Case reports.
    Abdelazim IA; Kanshaiym S
    J Family Med Prim Care; 2019 Sep; 8(9):3039-3041. PubMed ID: 31681690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid in Infertile Polycystic Ovary Syndrome Women Candidate for In Vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial.
    Zadeh Modarres S; Heidar Z; Foroozanfard F; Rahmati Z; Aghadavod E; Asemi Z
    Biol Trace Elem Res; 2018 Jun; 183(2):218-225. PubMed ID: 28875327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of metabolic syndrome in patients with polycystic ovary syndrome: A systematic review and meta-analysis.
    Khorshidi A; Azami M; Tardeh S; Tardeh Z
    Diabetes Metab Syndr; 2019; 13(4):2747-2753. PubMed ID: 31405703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review.
    Marchesan LB; Ramos RB; Spritzer PM
    Front Endocrinol (Lausanne); 2021; 12():759835. PubMed ID: 34737723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The risk of metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis.
    Behboudi-Gandevani S; Amiri M; Bidhendi Yarandi R; Noroozzadeh M; Farahmand M; Rostami Dovom M; Ramezani Tehrani F
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):169-184. PubMed ID: 28930378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiological mechanisms of gonadotropins- and steroid hormones-related genes in etiology of polycystic ovary syndrome.
    Shaaban Z; Khoradmehr A; Jafarzadeh Shirazi MR; Tamadon A
    Iran J Basic Med Sci; 2019 Jan; 22(1):3-16. PubMed ID: 30944702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and follicular fluid chemerin and chemerin mRNA expression in women with polycystic ovary syndrome: Systematic review and meta-analysis.
    Mansoori A; Amoochi-Foroushani G; Zilaee M; Hosseini SA; Azhdari M
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00307. PubMed ID: 34699139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic ovary syndrome and reproductive health of women: a curious association.
    Zehravi M; Maqbool M; Ara I
    Int J Adolesc Med Health; 2021 Apr; 33(6):333-337. PubMed ID: 33878255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
    Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Trial on The Effects of Magnesium-Zinc-Calcium-Vitamin D Co-Supplementation on Glycemic Control and Markers of Cardio-Metabolic Risk in Women with Polycystic Ovary Syndrome.
    Jamilian M; Maktabi M; Asemi Z
    Arch Iran Med; 2017 Oct; 20(10):640-645. PubMed ID: 29137465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of vitamin E supplementation on cardiometabolic risk factors, inflammatory and oxidative markers and hormonal functions in PCOS (polycystic ovary syndrome): a systematic review and meta-analysis.
    Tefagh G; Payab M; Qorbani M; Sharifi F; Sharifi Y; Ebrahimnegad Shirvani MS; Pourghazi F; Atlasi R; Shadman Z; Rezaei N; Mohammadi-Vajari E; Larijani B; Ebrahimpur M
    Sci Rep; 2022 Apr; 12(1):5770. PubMed ID: 35388031
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and Metabolic Responses to Magnesium Supplementation in Women with Polycystic Ovary Syndrome.
    Farsinejad-Marj M; Azadbakht L; Mardanian F; Saneei P; Esmaillzadeh A
    Biol Trace Elem Res; 2020 Aug; 196(2):349-358. PubMed ID: 31960275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review.
    Saei Ghare Naz M; Ramezani Tehrani F; Behroozi-Lak T; Mohammadzadeh F; Kholosi Badr F; Ozgoli G
    Res Rep Urol; 2020; 12():179-185. PubMed ID: 32440514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cortisol and polycystic ovarian syndrome - a systematic search and meta-analysis of case-control studies.
    Benjamin JJ; Kuppusamy M; Koshy T; Kalburgi Narayana M; Ramaswamy P
    Gynecol Endocrinol; 2021 Nov; 37(11):961-967. PubMed ID: 33818258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS).
    Atef MM; Abd-Ellatif RN; Emam MN; Abo El Gheit RE; Amer AI; Hafez YM
    Arch Biochem Biophys; 2019 Aug; 671():245-254. PubMed ID: 31251923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.
    Magzoub R; Kheirelseid EAH; Perks C; Lewis S
    Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():38-62. PubMed ID: 35149444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
    Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
    Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.